The ability of B cells to secrete antibodies (especially IgG) was significantly enhanced, and the pathogenic IgG could specifically target glycosylated membrane protein HSPA4, which could directly promote tumor metastasis by activating the HSPA4-binding protein ITGB5 and the downstream Src/NF-κB pathway. This evidence concerns the gene ITGB5 and neoplasm.